Anushya Pandian

Anushya Pandian has been in the research and development field since 2015. Anushya began as a Research Assistant at Harvard Medical School, followed by a Graduate Student Researcher and Teaching Assistant-RISE at Boston University in 2017. In 2018, they moved to Kintai Therapeutics as a Research Associate, Biology. In 2020, they joined Ultragenyx Pharmaceutical Inc. as a Senior Research Associate I, Cell Line Development. Currently, they are a Senior Research Associate at both Vesalius Therapeutics and Flagship Pioneering's FL81.

Anushya Pandian received a Bachelor of Arts - BA in Biochemistry from Regis College between 2012 and 2016. Anushya then pursued a Master of Arts - MA in Molecular Biology, Cell Biology & Biochemistry from Boston University between 2016 and 2018.